C12N 15/09
Recombinant dna-technology
Official title: Recombinant DNA-technology
C12N15/09 (Recombinant dna-technology) appears on 65,954 US grants and 105,709 published applications in this corpus.
Search patents in C12N- Granted patents
- 65,954
- Published applications
- 105,709
- Assignees
- 18,526
- Inventors
- 136,720
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 2 | 0 |
| 1977 | 0 | 0 |
| 1978 | 1 | 0 |
| 1979 | 1 | 0 |
| 1980 | 2 | 0 |
| 1981 | 7 | 0 |
| 1982 | 22 | 0 |
| 1983 | 27 | 0 |
| 1984 | 35 | 0 |
| 1985 | 40 | 0 |
| 1986 | 54 | 0 |
| 1987 | 92 | 0 |
| 1988 | 118 | 0 |
| 1989 | 159 | 0 |
| 1990 | 183 | 0 |
| 1991 | 211 | 0 |
| 1992 | 302 | 0 |
| 1993 | 350 | 0 |
| 1994 | 349 | 0 |
| 1995 | 381 | 0 |
| 1996 | 684 | 0 |
| 1997 | 1129 | 0 |
| 1998 | 1523 | 0 |
| 1999 | 1556 | 0 |
| 2000 | 1428 | 0 |
| 2001 | 1557 | 352 |
| 2002 | 1405 | 2097 |
| 2003 | 1302 | 3681 |
| 2004 | 1099 | 2969 |
| 2005 | 898 | 2906 |
| 2006 | 1280 | 2741 |
| 2007 | 1284 | 2319 |
| 2008 | 1072 | 2495 |
| 2009 | 1253 | 3163 |
| 2010 | 1687 | 3190 |
| 2011 | 1701 | 3349 |
| 2012 | 1821 | 3079 |
| 2013 | 1860 | 3424 |
| 2014 | 2237 | 3887 |
| 2015 | 2653 | 4083 |
| 2016 | 2733 | 4151 |
| 2017 | 2934 | 4229 |
| 2018 | 2979 | 4642 |
| 2019 | 3213 | 5619 |
| 2020 | 3407 | 5681 |
| 2021 | 3406 | 5988 |
| 2022 | 3330 | 6519 |
| 2023 | 3084 | 6702 |
| 2024 | 3102 | 7009 |
| 2025 | 3431 | 6514 |
| 2026 | 2570 | 4920 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Preventing and treating amyloid-beta deposition by stimulation of innate immunity6 Oct 2026US 12,751,964 B2New York University
- Method for optimized RIG-I ligands6 Oct 2026US 12,751,965 B2
- Composition for use in treating dystrophic epidermolysis bullosa6 Oct 2026US 12,751,974 B2Osaka University
- Methods and compositions of chondrisomes6 Oct 2026US 12,751,977 B2Children's Medical Center Corporation
- Tumor-targeting Salmonella gallinarum strain and use thereof6 Oct 2026US 12,751,978 B2Industry Foundation of Chonnam National University
- Transgenic model of human cardiomyopathy8 Oct 2026US 2026/0305586 A1Stichting Genetische Hartspierziekte PLN
- Humanized ace2-expressing transgenic mouse susceptible to sars-cov-2 virus infection and method for producing same8 Oct 2026US 2026/0305587 A1Seoul National University R&Db Foundation
- Methods and compositions for microbial delivery of double stranded rna8 Oct 2026US 2026/0305618 A1Rnaissance AG LLC
- Composition and Method for Topical Trans-spinal Delivery of Nucleic Acids and Small Molecules8 Oct 2026US 2026/0306414 A13P Biotechnologies, Inc.
- Active loading of biomolecular cargo into engineered vesicles8 Oct 2026US 2026/0306415 A1Northwestern University
Most cited
By later US patents
- Process for amplifying nucleic acid sequences5,960US 4,683,202 ACetus Corporation · 1987
- Mutant dwarfism gene of petunia5,133US 5,523,520 AGoldsmith Seeds, Inc. · 1996
- Recombinant immunoglobin preparations4,785US 4,816,567 AGenentech, Inc. · 1989
- Directed evolution of novel binding proteins2,450US 5,223,409 AProtein Engineering Corporation · 1993
- Soybean transformation and regeneration methods2,169US 5,968,830 AMississippi State University · 1999